article thumbnail

Wealthy Families Fuel $20bn Private Equity Buyout Wave

Private Equity Insights

Ultra-rich individuals and families worth more than $150bn are helping drive a resurgence in private equity buyouts, providing capital for some of the year’s biggest acquisitions to overcome a tough dealmaking environment. read more The post Wealthy Families Fuel $20bn Private Equity Buyout Wave appeared first on Private Equity Insights.

Buyout 130
article thumbnail

With Shares Surging on Talk of a Buyout, Is GXO Logistics a Buy?

The Motley Fool

GXO Logistics (NYSE: GXO) was spun off from XPO (NYSE: XPO) in 2021 with a lot of promise and bright prospects. The company was created as the world's largest independent, pure-play contract logistics company with close to 1,000 warehouses in North America and Europe. On Thursday, investors were greeted by news that GXO could sell itself.

Buyout 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

With Shares Down Nearly 70%, I'm Piling Into this Ultra-High-Yield Dividend Stock

The Motley Fool

They've made it more expensive for the company to borrow money to finance new investments and refinance existing funding, including the scheduled buyouts of convertible equity portfolio financing (CEPFs). It intends to use the proceeds to complete all the planned buyouts of CEPFs through 2025.

Buyout 240
article thumbnail

Blackstone, KKR, CVC curbed by China’s IPO clampdown

Private Equity Wire

This has left significant amounts of capital locked in China, with uncertain prospects for future returns. As a result, buyout groups have sought alternative exit routes, such as selling stakes to domestic or multinational firms or other private equity groups.

article thumbnail

Wall Street Thinks This Tiny Biotech Company Could Soar Soon

The Motley Fool

While estimates vary, Wall Street analysts aren't overly excited about the commercial prospects of either therapy. An FDA-approved gene therapy for SCD, after all, will probably transform the biotech into a top buyout candidate in early 2024. However, a buyout is not guaranteed. 20, Bluebird's shares ought to shoot northward.

Companies 246
article thumbnail

CCMP Buys Catering Platform from Falfurrias

Private Equity Professional

In December 2023, Falfurrias closed its first dedicated growth buyout fund, Falfurrias Growth Partners I LP , with $400 million in capital commitments.

Buyout 130
article thumbnail

2 Cathie Wood Stocks to Buy Hand Over Fist Right Now

The Motley Fool

An approval may also open the door to a buyout. To date, most large pharma companies have chosen the partnering route over a buyout to gain exposure to this groundbreaking tech. And unlike Tesla, Wood and most Wall Street analysts seem to be in agreement about the exponential growth prospects of this gene-editing stock.

Buyout 246